Final FY 2024 Health and Foreign Operations Funding Bills Avoid Dangerous Cuts to Infectious Diseases Programs
Congress’s FY 2024 Labor, Health and Human Services and State and Foreign Operations bills that include funding for IDSA priorities are outlined below. The legislation averts proposed cuts to the National Institute of Allergy and Infectious Diseases and other ID/HIV programs. The bill also includes a one-year extension of expired President’s Emergency Plan for AIDS Relief provisions.
IDSA is disappointed that funding for the Bio-Preparedness Workforce Pilot Program was not included in Congress’ FY 2024 Labor, Health and Human Services appropriations bill despite bipartisan support for the program, missing an opportunity to close the widening ID workforce gap.
IDSA continues to urge Congress to provide sufficient funding in FY 2025 for ID and HIV programs.
Labor, Health and Human Services Appropriations Bill
• $197 million for CDC’s Antibiotic Resistance Solutions Initiative, level funding with FY 2023;
• $24 million in funding for the National Healthcare Safety Network at CDC, level funding;
• $40 million in funding for the Advanced Molecular Detection initiative at CDC, level funding;
• $6.562 billion for the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, level funding;
• $692.8 million for the CDC’s Center for Global Health, level funding;
• $23 million for the CDC’s Infectious Diseases and Opioids program, level funding;
• $95.162 million for NIH’s Fogarty International Center, level funding;
• $1.015 billion for the Biomedical Advanced Research and Development Authority at the Administration for Strategic Preparedness and Response, a $65 million increase;
• $825 million for Project BioShield at ASPR, a $5 million increase over FY 2023.
State and Foreign Operations Appropriations Bill
• $700 million for USAID global health security efforts, a significant cut from FY 2023 levels at $900 million and a further cut considering that this number includes funding for the U.S. contribution to the Pandemic Fund and CEPI, which leaves potentially $350 million for bilateral USAID global health security programming;
• $1.65 billion for the Global Fund to Fight AIDS, Tuberculosis and Malaria, a cut from FY 2023; however, this amount is in line with how much the U.S. can legally contribute based on contributions from other donors;
• $4.395 billion for the President’s Emergency Plan for AIDS Relief, level funding;
• $394.5 million for the USAID global TB program, level funding.